June 2008 Oncology News International

Publication
Article

Cover Story

Dr. Kanti Rai, researcher and 'doctor's doctor'

Trial targeting stem cells in advanced breast ca begins

US cancer patients still plagued by undertreated pain

DEPARTMENTS

Focus on Breast Cancer

Breast US finds cancer that mammo misses in at-risk pts

Zoledronic acid ups PFS in younger early-stage pts

Focus on Colon Cancer

Adjuvant bevacizumab/chemo/RT prevents local recurrence in advanced rectal cancer

Elderly metastatic colorectal cancer patients can receive standard regimens with irinotecan

News & Analysis

Everolimus effective in treating metastatic RCC patients

Focus on Hematology

Novel BiTE antibody mediates contact between T cells and cancer cells

Little benefit seen for personalized anti-Id vaccine in non-Hodgkin’s lymphoma

Focus on Prostate Cancer

MRI can monitor the prostate for local progression after ultrasonic ablation

People & Places

Young fashion designer translates cancer fears into fierce frocks

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Clinical trials conducted in recent years demonstrate the benefit of integrative oncology for patients undergoing treatment for cancer.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
4 experts in this video
2 experts in this video
Related Content
According to comparative single-cell transcriptome analyses, NOTCH1 deficiency facilitated a more immunologically active microenvironment in ESCC tumors.

NOTCH1 Mutational Status May Predict ICI Outcomes in Esophageal Cancer

Roman Fabbricatore
April 28th 2025
Article

According to comparative single-cell transcriptome analyses, NOTCH1 deficiency facilitated a more immunologically active microenvironment in ESCC tumors.

A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.

Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors

William R. Kennedy, MD
April 28th 2025
Podcast

A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.

Treatment with daratumumab-based combination therapies may drive minimal residual disease conversion rates in patients with newly diagnosed multiple myeloma.

Assessing CD38 Monoclonal Antibody-Based Regimens in NDMM

Roman Fabbricatore
April 27th 2025
Article

Treatment with daratumumab-based combination therapies may drive minimal residual disease conversion rates in patients with newly diagnosed multiple myeloma.

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
April 21st 2025
Podcast

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

84 EQUALS: Vaginal/Sexual Health in Patients With Estrogen Receptor–Positive/HER2- Metastatic Breast Cancer

84 EQUALS: Vaginal/Sexual Health in Patients With Estrogen Receptor–Positive/HER2- Metastatic Breast Cancer

David J. Portman;Timothy Pluard;Jane L. Meisel, MD;Kelly Shanahan;Sarah Sammons, MD;Elizabeth Attias
April 26th 2025
Article
SBRT Shows Positive 3-Year OS Rate in Newly Diagnosed Early-Stage HCC

SBRT Shows Positive 3-Year OS Rate in Newly Diagnosed Early-Stage HCC

Tim Cortese
April 26th 2025
Article

SBRT demonstrated positive 3-year outcomes as a treatment in patients with early-stage HCC based on results from the phase 2 STRSPH trial.